by The global Branched Stent Grafts market size is expected to be worth around US$ 501.53 Mn by 2030, according to a new report by Vision Research Reports.
Branched Stent Grafts Market (By Type: Iliac Stent, Others; By Application: EVAR) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38320
| Report Coverage | Details |
| Market Size | US$ 501.53 Mn by 2030 |
| Growth Rate | CAGR of 12.9% From 2021 to 2030 |
| Base year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Type, Application |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | Medtronic; Biotronik: Alvimedica; Endocor GmbH; Eucatech AG; Merit Medical Systems; Abbott; Cook Medical; Cardinal Health (Cordis); Boston Scientific Corp.; Terumo Corp. |
Report Highlights
Iliac stents accounted for a considerable share of over 48% in 2021 and are expected to grow at a CAGR of 10.9% during the forecast period. The increase in the incidence of Cardiovascular Diseases (CVDs) around the world is the key factor driving the segment growth. Rapid technological advancements and widespread acceptance of stenting procedures are also expected to boost the segment growth over the forecast period.
The others segment is expected to hold the largest market share by 2030 growing at the fastest CAGR from 2021 to 2030. The segment comprises renal, celiac, gastric, femoral, fenestrated/branched, super mesenteric stent graft systems. The increasing geriatric population across the globe, which has a high incidence of the stomach or digestive diseases, is the key factor supporting the segment growth.
Branched stent-grafts find their application in EVAR procedures. EVAR is further sub-segmented into chimney, Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR), and others. The others segment is accounted for the largest market share of more than 50% in 2021. Recent developments in branched stent grafts have created a way to treat multifaceted aortic aneurysms including visceral arteries.
In 2021, North America held the largest revenue share of more than 59%. This can be attributed to the presence of well-developed healthcare infrastructure, key players, and reimbursement coverage in the region. In addition, the regional market is highly competitive due to the strong presence of major market players. On the other hand, Asia Pacific is anticipated to be the fastest-growing regional market with a CAGR of more than 9% over the forecast period.
Key Players
- Medtronic
- Biotronik
- Alvimedica
- Endocor GmbH
- Eucatech AG
- Merit Medical Systems
- Abbott
- Cook Medical
- Cardinal Health (Cordis)
- Boston Scientific Corp.
- Terumo Corp.
Market Segmentation
- Type Outlook
- Iliac Stent
- Others
- Application Outlook (Volume, Units; Revenue, USD Million, 2021 – 2028)
- EVAR
- FEVAR
- Chimney
- Others
- EVAR
- Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Greece
- The Netherlands
- Asia Pacific
- Japan
- China
- India
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- North America
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38320
The study objectives of this report are:
- To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
- Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
- To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Branched Stent Grafts Market, By Application
7.1. Branched Stent Grafts Market, by Application, 2021-2030
7.1.1. EVAR
7.1.1.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Branched Stent Grafts Market, By Type
8.1. Branched Stent Grafts Market, by Type, 2021-2030
8.1.1. Iliac Stent
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Others
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Branched Stent Grafts Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Application (2016-2030)
9.1.2. Market Revenue and Forecast, by Type (2016-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Application (2016-2030)
9.1.3.2. Market Revenue and Forecast, by Type (2016-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Application (2016-2030)
9.1.4.2. Market Revenue and Forecast, by Type (2016-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Application (2016-2030)
9.2.2. Market Revenue and Forecast, by Type (2016-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Application (2016-2030)
9.2.3.2. Market Revenue and Forecast, by Type (2016-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Application (2016-2030)
9.2.4.2. Market Revenue and Forecast, by Type (2016-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Application (2016-2030)
9.2.5.2. Market Revenue and Forecast, by Type (2016-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Application (2016-2030)
9.2.6.2. Market Revenue and Forecast, by Type (2016-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Application (2016-2030)
9.3.2. Market Revenue and Forecast, by Type (2016-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Application (2016-2030)
9.3.3.2. Market Revenue and Forecast, by Type (2016-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Application (2016-2030)
9.3.4.2. Market Revenue and Forecast, by Type (2016-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Application (2016-2030)
9.3.5.2. Market Revenue and Forecast, by Type (2016-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Application (2016-2030)
9.3.6.2. Market Revenue and Forecast, by Type (2016-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Application (2016-2030)
9.4.2. Market Revenue and Forecast, by Type (2016-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Application (2016-2030)
9.4.3.2. Market Revenue and Forecast, by Type (2016-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Application (2016-2030)
9.4.4.2. Market Revenue and Forecast, by Type (2016-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Application (2016-2030)
9.4.5.2. Market Revenue and Forecast, by Type (2016-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Application (2016-2030)
9.4.6.2. Market Revenue and Forecast, by Type (2016-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Application (2016-2030)
9.5.2. Market Revenue and Forecast, by Type (2016-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Application (2016-2030)
9.5.3.2. Market Revenue and Forecast, by Type (2016-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Application (2016-2030)
9.5.4.2. Market Revenue and Forecast, by Type (2016-2030)
Chapter 10. Company Profiles
10.1. Medtronic
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Biotronik
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Alvimedica
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Endocor GmbH
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Eucatech AG
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Merit Medical Systems
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Abbott
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Cook Medical
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Cardinal Health (Cordis)
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Boston Scientific Corp.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Terumo Corp.
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38320
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com
